| Date | Name | Shares | Transaction | Value |
|
Apr 28, 2026
| John J. Corkrean Executive VP and CFO |
33,456
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
|
Apr 28, 2026
| Heather A. Campe Sr. VP, International Growth |
5,569
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
|
Apr 21, 2026
| Teresa Joy Rasmussen Director |
3,391
| Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $65.83 per share |
223,229.53
|
|
Mar 3, 2026
| Charles T. Lauber Director |
10,180
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
|
Mar 3, 2026
| Daniel Lars Florness Director |
29,730
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
|
Mar 3, 2026
| Thomas W. Handley Director |
77,480
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
|
Mar 3, 2026
| Michael J. Happe Director |
14,386
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
|
Mar 3, 2026
| Teresa Joy Rasmussen Director |
20,840
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
|
Mar 3, 2026
| Ruth S. Kimmelshue Director |
33,362
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
|
Jan 28, 2026
| Celeste Beeks Mastin President and CEO; Director |
N/A
| Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 |
0.00
|
|
Jan 28, 2026
| Charles T. Lauber Director |
1,351
| Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $60.07 per share |
81,154.57
|
|
Jan 28, 2026
| Celeste Beeks Mastin President and CEO; Director |
24,514
| Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $60.07 per share |
1,472,555.98
|
|
Jan 28, 2026
| Heather A. Campe Sr. VP, International Growth |
23,749
| Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $60.07 per share |
1,426,602.43
|
|
Jan 28, 2026
| Celeste Beeks Mastin President and CEO; Director |
28,451
| Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $60.07 per share |
1,709,051.57
|
|
Jan 28, 2026
| Heather A. Campe Sr. VP, International Growth |
24,430
| Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $60.07 per share |
1,467,510.10
|
|
Jan 28, 2026
| Heather A. Campe Sr. VP, International Growth |
24,237
| Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $60.07 per share |
1,455,916.59
|
|
Jan 28, 2026
| Xinyu Du Sr. VP, Global R&D |
N/A
| Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 |
0.00
|
|
Jan 28, 2026
| Heather A. Campe Sr. VP, International Growth |
N/A
| Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 |
0.00
|
|
Jan 28, 2026
| Muhammad Shahbaz Malik Senior VP, BAS |
12,958
| Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $60.07 per share |
778,387.06
|
|
Jan 28, 2026
| Celeste Beeks Mastin President and CEO; Director |
29,865
| Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $60.07 per share |
1,793,990.55
|